Cosamin Verde by NMx Wellness Innovations — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed

Label Data

2 Tablet(s) Serving Size

40 Servings

Other Combinations Product Type

40% Evidence Coverage

Supplement Facts — Evidence Check

Calories

10 Calorie(s)

Total Carbohydrates

1 Gram(s) (1% DV)

Protein

1 Gram(s) (2% DV)

Glucosamine HCl

1.5 Gram(s)

📊 Market median: 1000.0mg (1115 products) 📚 22 studies (Tier A: 0, B: 9)

This product: 1.5mg

Proprietary ASU Powder, AKBA, and Green Tea Complex

300 mg

📊 Market median: 375.0mg (171 products) 📚 30 studies (Tier A: 1, B: 14)

This product: 300mg

Other Ingredients

Microcrystalline Cellulose Contains Less Than 2% of

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (100% of products) Structure/Function (89% of products) Nutrient (16% of products)

Target Groups

Vegetarian Adult (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

Directions for use: Take 2 tablets daily until desired comfort is reached. May reduce number of tablets taken daily to maintain comfort level. Tablets may be taken all at once or divided with meals.

⚠️ Warnings & Precautions

If you have any condition that requires medical attention always consult your physician before taking any dietary supplement.

Important: Tamper evident seal under cap. Do not use if seal is broken or missing.

Contains: Soy.

🧪 Formulation Notes

Gluten-free

Vegetarian formula

Glucosamine HCl (non-shellfish) ASU (NMX1000) AKBA (QUIKLOX) Green Tea

New vegetarian formula

Contains: Soy.

Additional Information

Keep in a cool, dry place.

NSF Contents Tested & Certified www.nsf.org

Learn more: Cosamin.com or 1-877-Cosamin (1-877-267-2646)

Researched, tested & certified

For joint health

Psalm 86:12

Product Details

UPC / SKU 7 55970 85001 7

DSLD Entry Date 2019-08-23

Product Type Other Combinations

Form Tablet or Pill

Brand NMx Wellness Innovations

DSLD ID 205136

Data Updated 2026-04-11

Research Evidence

39 Research Sources

50 Avg Quality Score

20 Rct

9 Meta Analysis

4 Clinical Trial

3 Systematic Review

1 Regulatory Source

1 Openfda Safety

B Interventions for the management of temporomandibular joint osteoarthritis

Systematic Review The Cochrane database of systematic reviews 2012

PubMed DOI Cochrane

B Glucosamine therapy for treating osteoarthritis

Meta Analysis The Cochrane database of systematic reviews 2005

PubMed Cochrane

B Chondroitin for osteoarthritis

Meta Analysis The Cochrane database of systematic reviews 2015

PubMed DOI Cochrane

B Efficacy and safety of the combination of glucosamine and chondroitin for knee osteoarthritis: a systematic review and meta-analysis

Meta Analysis Archives of orthopaedic and trauma surgery 2023

PubMed DOI

B Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis

Rct The New England journal of medicine 2006

PubMed

B Oral Glucosamine in the Treatment of Temporomandibular Joint Osteoarthritis: A Systematic Review

Systematic Review International journal of molecular sciences 2023

PubMed DOI

B Scientific Opinion on glucosamine and joint health

Regulatory Source EFSA Journal 2009

DOI

B Clinical Efficacy and Safety of Chondroitin Combined with Glucosamine in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis

Meta Analysis Computational and mathematical methods in medicine 2022

PubMed DOI

B Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib

Rct Annals of the rheumatic diseases 2016

PubMed DOI

B Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials

Meta Analysis Journal of orthopaedic surgery and research 2018

PubMed DOI

View all evidence for Glucosamine →